
Tenvir-em
Tenofovir Disoproxil, Emtricitabine
300mg + 200mg
Tenofovir and emtricitabine tablets for HIV and pre-exposure prophylaxis. Combining two antivirals lowers the risk of resistance.
Human immunodeficiency virus 1 (HIV-1) infection is caused by a virus that attacks the body’s immune system, weakening its ability to fight off illness and increasing the risk of serious conditions.

Tenofovir Disoproxil, Emtricitabine
300mg + 200mg
Tenofovir and emtricitabine tablets for HIV and pre-exposure prophylaxis. Combining two antivirals lowers the risk of resistance.

Bictegravir, Emtricitabine, Tenofovir Alafenamide
50mg + 200mg + 25mg
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.

Dolutegravir, Lamivudine, Tenofovir Disoproxil
50mg + 300mg + 300mg
Dolutegravir and lamivudine tablets for HIV-1 infection. It blocks two different steps in the HIV lifecycle.

Tenofovir Disoproxil, Efavirenz, Emtricitabine
300mg + 600mg + 200mg
Tenofovir disoproxil and efavirenz tablets for HIV-1. They combine two antiretrovirals to keep the virus in check.
The nine listed products are all tablets. Five combine two or three active ingredients into a single pill, while four contain one active ingredient each. The medicines represented include Tenofovir Disoproxil, Emtricitabine, lamivudine, dolutegravir, efavirenz, zidovudine, bictegravir and tenofovir alafenamide. These belong to several classes of antiretroviral medicine that interrupt different steps in how HIV copies itself inside the body.